bpc-157 ulcerative colitis clinical trial results Pentadecapeptide BPC 157, in trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system Peptide Therapy in Denver, Bottle Amount:1 Bottle Evexias BPC-157
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12